Meta-analysis : Effects of Eicosapentaenoic Acid in Clinical Trials in Depression
暂无分享,去创建一个
J. Mann | S. Ellis | J. | Amy L. Geant | M. Sublette | J. Mann
[1] Shih-Yi Huang,et al. A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression , 2010, Biological Psychiatry.
[2] T. Harada,et al. Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells. , 2010, The Journal of nutritional biochemistry.
[3] C. Pariante,et al. Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α–Induced Depression by Regulating Polyunsaturated Fatty Acids Levels , 2010, Biological Psychiatry.
[4] P. Rogers,et al. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. , 2010, The American journal of clinical nutrition.
[5] C. Runyan,et al. Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.
[6] D. Kiesewetter,et al. Whole-body synthesis secretion of docosahexaenoic acid from circulating eicosapentaenoic acid in unanesthetized rats , 2009, Journal of Lipid Research.
[7] J. Mehta,et al. Effect of fish oils containing different amounts of EPA, DHA, and antioxidants on plasma and brain fatty acids and brain nitric oxide synthase activity in rats , 2009, Upsala journal of medical sciences.
[8] R. Carney,et al. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. , 2009, JAMA.
[9] J. Martins. EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials , 2009, Journal of the American College of Nutrition.
[10] S. Rapoport,et al. Bipolar disorder and mechanisms of action of mood stabilizers , 2009, Brain Research Reviews.
[11] R. McNamara. Membrane Omega-3 Fatty Acid Deficiency as a Preventable Risk Factor for Comorbid Coronary Heart Disease in Major Depressive Disorder , 2009, Cardiovascular psychiatry and neurology.
[12] M. Fava,et al. A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. , 2009, The Journal of clinical psychiatry.
[13] C. Cooper,et al. The relationship between depression and diabetes mellitus: findings from the Hertfordshire Cohort Study , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[14] Charles L. Raison,et al. Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.
[15] F. Calon,et al. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.
[16] R. Munhoz,et al. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. , 2008, Journal of affective disorders.
[17] Melinda F. Davis,et al. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. , 2008, Journal of affective disorders.
[18] D. Jump. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription , 2008, Current opinion in lipidology.
[19] Xiao-Hua Zhou,et al. Statistical Methods for Meta‐Analysis , 2008 .
[20] C. Pariante,et al. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. , 2008, The Journal of clinical psychiatry.
[21] G. Parker,et al. Omega-3 Fatty Acids as a Treatment for Perinatal Depression: Randomized Double-Blind Placebo-Controlled Trial , 2008, The Australian and New Zealand journal of psychiatry.
[22] T. Peters,et al. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial , 2008, British Journal of Nutrition.
[23] M. Maes,et al. Why fish oils may not always be adequate treatments for depression or other inflammatory illnesses: docosahexaenoic acid, an omega-3 polyunsaturated fatty acid, induces a Th-1-like immune response. , 2007, Neuro endocrinology letters.
[24] S. Rapoport,et al. Antimanic therapies target brain arachidonic acid signaling: lessons learned about the regulation of brain fatty acid metabolism. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.
[25] P. Caputi,et al. Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[26] Meng-Chuan Huang,et al. Differential tissue dose responses of (n-3) and (n-6) PUFA in neonatal piglets fed docosahexaenoate and arachidonoate. , 2007, The Journal of nutrition.
[27] K. Su,et al. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. , 2007, The Journal of clinical psychiatry.
[28] P. Tso,et al. Selective Deficits in the Omega-3 Fatty Acid Docosahexaenoic Acid in the Postmortem Orbitofrontal Cortex of Patients with Major Depressive Disorder , 2007, Biological Psychiatry.
[29] A. Simmons,et al. Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder , 2007, Journal of psychopharmacology.
[30] J. Lake,et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. , 2006, The Journal of clinical psychiatry.
[31] M. Frye,et al. Double-Blind, Randomized, Placebo-Controlled Trials of Ethyl-Eicosapentanoate in the Treatment of Bipolar Depression and Rapid Cycling Bipolar Disorder , 2006, Biological Psychiatry.
[32] Anthony Windust,et al. Omega-3 fatty acids, energy substrates, and brain function during aging. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.
[33] J. Mann,et al. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. , 2006, The American journal of psychiatry.
[34] P. Calder. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.
[35] R. Belmaker,et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. , 2006, The American journal of psychiatry.
[36] G. Parker,et al. Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression , 2006, Psychiatry Research.
[37] J. Hibbeln,et al. The relationship between folate and docosahexaenoic acid in men , 2006, European Journal of Clinical Nutrition.
[38] S. Frangou,et al. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study , 2006, British Journal of Psychiatry.
[39] W. Smith. Cyclooxygenases, peroxide tone and the allure of fish oil. , 2005, Current opinion in cell biology.
[40] D. Horrobin,et al. Ethyl-EPA in Alzheimer's disease--a pilot study. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.
[41] D. V. van Raalte,et al. Peroxisome Proliferator-Activated Receptor (PPAR)-α: A Pharmacological Target with a Promising Future , 2004, Pharmaceutical Research.
[42] P. Calder. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. , 2004, Clinical science.
[43] Gwenn S. Smith,et al. Evidence for a role of the arachidonic acid cascade in affective disorders: a review. , 2004, Bipolar disorders.
[44] M. Maes,et al. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. , 2003, Life sciences.
[45] Shih-Yi Huang,et al. Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial , 2003, European Neuropsychopharmacology.
[46] A. Simopoulos. Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases , 2002, Journal of the American College of Nutrition.
[47] A. Kafatos,et al. Depression and adipose essential polyunsaturated fatty acids. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.
[48] D. Horrobin,et al. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. , 2002, Archives of general psychiatry.
[49] R. Belmaker,et al. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. , 2002, The American journal of psychiatry.
[50] B. Puri,et al. EICOSAPENTAENOIC ACID IN TREATMENT‐RESISTANT DEPRESSION ASSOCIATED WITH SYMPTOM REMISSION, STRUCTURAL BRAIN CHANGES AND REDUCED NEURONAL PHOSPHOLIPID TURNOVER , 2001, International journal of clinical practice.
[51] N. Salem,et al. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. , 2001, Journal of lipid research.
[52] G. Watts,et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. , 2000, The American journal of clinical nutrition.
[53] L. Madsen,et al. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. , 1999, The Biochemical journal.
[54] GISSI-Prevenzione Investigators,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.
[55] D. Horrobin,et al. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. , 1998, Journal of affective disorders.
[56] D. Horrobin,et al. Depletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients , 1998, Biological Psychiatry.
[57] R. Smith,et al. Fatty acids, cytokines, and major depression. , 1998, Biological psychiatry.
[58] P. Lovibond,et al. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. , 1995, Behaviour research and therapy.
[59] B. Carroll,et al. A Depression Rating Scale for Children , 1979, Pediatrics.
[60] M. Åsberg,et al. A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.
[61] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[62] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[63] Andrew H. Miller,et al. Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.
[64] A. Stoll,et al. Omega 3 Fatty Acids in Bipolar Disorder A Preliminary Double-blind, Placebo-Controlled Trial , 1999 .
[65] H. Meltzer,et al. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. , 1996, Journal of affective disorders.
[66] R. Rosenthal. Parametric measures of effect size. , 1994 .
[67] Harry Smith,et al. Applied Regression Analysis , 1968 .